Literature DB >> 15606200

DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity.

Alfredo M Angeles-Boza1, Patricia M Bradley, Patty K-L Fu, Sara E Wicke, John Bacsa, Kim R Dunbar, Claudia Turro.   

Abstract

Two new dirhodium(II) complexes possessing the intercalating dppz ligand (dppz = dipyrido[3,2-a:2',3'-c]phenazine), cis-[Rh(2)(mu-O(2)CCH(3))(2)(dppz)(eta(1)-O(2)CCH(3))(CH(3)OH)](+) (1) and cis-[Rh(2)(mu-O(2)CCH(3))(2)(dppz)(2)](2+) (2), were synthesized and characterized as potential agents for photochemotherapy. Various techniques show that 1 binds to DNA through intercalation, although some aggregation of the complex on the DNA surface is also present. In contrast, 2 does not intercalate between the DNA bases; however, strong hypochromic behavior is observed in the presence of DNA, which can be attributed to intermolecular pi-stacking of 2 enhanced by the polyanion. The apparent DNA binding constants determined using optical titrations are compared to those from dialysis experiments. Both complexes photocleave pUC18 plasmid in vitro under irradiation with visible light (lambda(irr) >or= 395 nm, 15 min), resulting in the nicked, circular form. Greater photocleavage is observed for 1 relative to 2, which may be due to the ability of 1 to intercalate between the DNA bases. The cytotoxicity toward human skin cells (Hs-27) measured as the concentration at which 50% cell death is recorded, LC(50), was found to be 135 +/- 8 microM for 2 in the dark (30 min), which is significantly lower than those of 1 (LC(50) = 27 +/- 2 microM) and Rh(2)(O(2)CCH(3))(4) (LC(50) = 15 +/- 2 microM). Irradiation of cell cultures containing 1 and Rh(2)(O(2)CCH(3))(4) with visible light (400-700 nm, 30 min) has little effect on their cytotoxicity, with LC(50) values of 21 +/- 3 and 13 +/- 2 microM, respectively. Interestingly, a 3.4-fold increase in the toxicity of 2 is observed when the cell cultures are irradiated (400-700 nm, 30 min), resulting in LC(50) = 39 +/- 1 microM. The greater toxicity of 1 compared to 2 in the dark may be related to the ability of the former compound to intercalate between the DNA bases. The lower cytotoxicity of 2, together with its significantly greater photocytotoxicity, makes this complex a potential agent for photodynamic therapy (PDT). These results suggest that intercalation or strong DNA binding may not be a desirable property of a potential PDT agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606200     DOI: 10.1021/ic049091h

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  12 in total

1.  Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.

Authors:  Duraisamy Senthil Raja; Nattamai S P Bhuvanesh; Karuppannan Natarajan
Journal:  J Biol Inorg Chem       Date:  2011-09-20       Impact factor: 3.358

2.  A Study on Spectro-Analytical Aspects, DNA - Interaction, Photo-Cleavage, Radical Scavenging, Cytotoxic Activities, Antibacterial and Docking Properties of 3 - (1 - (6 - methoxybenzo [d] thiazol - 2 - ylimino) ethyl) - 6 - methyl - 3H - pyran - 2, 4 - dione and its Metal Complexes.

Authors:  Mudavath Ravi; Kishan Prasad Chennam; B Ushaiah; Ravi Kumar Eslavath; Shyam Perugu; Rajanna Ajumeera; Ch Sarala Devi
Journal:  J Fluoresc       Date:  2015-08-28       Impact factor: 2.217

3.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

4.  Dual Photoreactivity of a New Rh2(II,II) Complex for Biological Applications.

Authors:  Regina N Akhimie; Jessica K White; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-04-18       Impact factor: 2.545

5.  [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.

Authors:  Robert N Garner; Judith C Gallucci; Kim R Dunbar; Claudia Turro
Journal:  Inorg Chem       Date:  2011-08-31       Impact factor: 5.165

Review 6.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

7.  Biophysical insights into the interaction of two enantiomers of Ru(II) complex [Ru(bpy)2(7-CH3-dppz)]2+ with the RNA poly(U-A⁎U) triplex.

Authors:  Zhan Dong; Xiaohua Liu; Lifeng Tan
Journal:  J Biol Inorg Chem       Date:  2020-10-11       Impact factor: 3.358

8.  Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated Macrophages.

Authors:  Nicholas Toupin; Mackenzie K Herroon; Randolph P Thummel; Claudia Turro; Izabela Podgorski; Heather Gibson; Jeremy J Kodanko
Journal:  Chemistry       Date:  2022-03-24       Impact factor: 5.020

9.  Binding properties of Ru(II) polypyridyl complexes with poly(U)·poly(A)*poly(U) triplex: the ancillary ligand effect on third-strand stabilization.

Authors:  Li-Feng Tan; Ling-Jun Xie; Xiao-Nan Sun
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

10.  A new palladium-based antiproliferative agent: synthesis, characterization, computational calculations, cytotoxicity, and DNA binding properties.

Authors:  Mohammad Aminzadeh; Hassan Mansouri-Torshizi; Roghayeh Aleeshah; Khatereh Abdi; Maryam Saeidifar
Journal:  Biometals       Date:  2021-08-07       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.